Video

Dr. Gieschen on Patient Selection for Radiation in Prostate Cancer

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses patient selection for radiation in the treatment of prostate cancer.

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses patient selection for radiation in the treatment of prostate cancer.

There are several patients who are considered eligible to receive radiation therapy, Gieschen says. Patients ranging from low-risk to high-risk disease can be treated with radiation, but there are competing modalities in this space, such as prostatectomy. Although high-risk patients are usually treated with surgery, Gieschen notes that these patients can also benefit from radiation treatment.

In the definitive setting, the goal of radiation therapy is to shrink the cancer as much as possible and potentially cure the patient, whereas in the palliative setting, this approach is used to stabilize prostate-specific antigen levels that naturally rise after surgery.

Related Videos
Erminia Massarelli, MD, PhD, MS
Karen L. Reckamp, MD, MS
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Tanios Bekaii-Saab, MD, FACP
Moritz Fürstenau, MD
Jun Gong, MD
Thierry Facon, MD
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School